Skip to main content
. Author manuscript; available in PMC: 2024 Jul 31.
Published in final edited form as: AIDS Care. 2022 May 16;35(1):16–24. doi: 10.1080/09540121.2022.2067313

Table 6.

Completion of follow-up visits and retesting among SV survivors who initiated PEP in the intervention period (n = 65), by area of residence.

Rural (n = 48)
Urban (n = 17)
Total (n = 65)*
Consent for home visit
(n = 39)
No consent for home visit
(n = 9)
Total
(n = 48)
Consent for home visit
(n = 10)
No consent for home visit
(n = 7)
Total
(n = 17)
Consent for home visit
(n = 49)
No consent for home visit
(n = 16)
Total
(n = 65)
SV survivors initiating PEP who completed 1-month follow-up visit (4 missing - rural) 24 (89%) 3 (11%) 27 4 (80%) 1 (20%) 5 28 (88%) 4 (12%) 32
SV survivors who initiated PEP and retested at 1-month follow-up visit (proportion among those who had a visit) 23 (96%) 3 (100%) 26 (96%) 4 (100%) 1 (100%) 5 (100%) 27 (97%) 4 (100%) 31 (97%)
SV survivors initiating PEP who completed 3-month follow-up visit (6 missing - rural) 25 (96%) 1 (4%) 26 2 (100%) 0 2 27 (96%) 1 (4%) 28
SV survivors who initiated PEP and retested at 3-month follow-up visit (proportion among those who had a visit) 25 (100%) 1 (100%) 26 (100%) 2 (100%) 0 2 (100%) 27 (100%) 1 (100%) 28 (100%)
SV survivors initiating PEP who completed 6-month follow-up visit (9 missing rural; 1 missing urban) 19 (95%) 1 (5%) 20 1 (100%) 0 1 20 (95%) 1 (5%) 21
SV survivors who initiated PEP and retested at 6-month follow-up visit (proportion among those who had a visit) 19 (100%) 1 (100%) 20 (100%) 1 (100%) 0 1 (100%) 20 (100%) 1 (100%) 21 (100%)
*

No information on follow-up care/visits/consent for home visits for two SV survivors.